HRT Financial’s Bio-Techne TECH Stock Holding History

HRT Financial’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Sell	17,500 -409,300	-96%	-$22.1M	﹤0.01%	2037
2026 Q1	$22.3M	Buy	+426,800	New	+$25.6M	0.06%	307

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HRT Financial's TECH Position: Q2 2026 in Review

HRT Financial opened a new position in Bio-Techne (TECH) in Q2 2026: 203,140 shares worth $14.4M. The stake represents 0.03% of the portfolio and ranks #614 among its holdings. This is a return to the name: HRT Financial previously reported a position in TECH as recently as Q2 2025.

HRT Financial first reported a position in TECH in Q3 2019 and has held it in 12 quarters since. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

HRT Financial held 203,140 shares of Bio-Techne worth $14.4M as of Q2 2026.
Bio-Techne was a new HRT Financial position in Q2 2026.
Bio-Techne made up 0.03% of HRT Financial's portfolio in Q2 2026, its #614 holding.
HRT Financial first reported a position in Bio-Techne in Q3 2019 and has held it in 12 quarters since.
597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.